Parkinson’s disease GWAS-linked Park16 variant is associated with a lower risk of cognitive impairment: a 4-year observational study

Parkinson’s disease GWAS-linked Park16 variant is associated with a lower risk of cognitive impairment: a 4-year observational study
Eur J Neurol. 2023 May 25. doi: 10.1111/ene.15893. Online ahead of print.ABSTRACTBACKGROUND: Genome wide association study (GWAS)-linked variant (Park16 rs6679073) modulates the risk of Parkinson's disease (PD). We postulate that there may be differences in clinical characteristics between Park16 rs6679073 carriers and non-carriers.AIM: In a prospective study, we investigate the clinical characteristics between Park16 rs6679073 A allele carriers and non-carriers ... read more
Source: PubMedPublished on 2023-05-25By Bin Xiao